Literature DB >> 31972802

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES AFTER SUBTHRESHOLD MICROPULSE YELLOW LASER IN DIABETIC MACULAR EDEMA.

Stela Vujosevic1, Valentina Gatti1, Andrea Muraca1, Marco Brambilla2, Edoardo Villani3,4, Paolo Nucci3,4, Luca Rossetti5, Stefano De Cilla'1,6.   

Abstract

PURPOSE: To assess changes on optical coherence tomography (OCT) angiography in diabetic macular edema (DME) treated with subthreshold micropulse yellow laser (SMPL) over a period of 6 months.
METHODS: Thirty-five eyes (35 consecutive patients) with treatment-naive DME prospectively underwent (at baseline, 3 and 6 months) best-corrected visual acuity, swept-source OCT angiography/OCT, and fundus autofluorescence. Following parameters were evaluated on OCT angiography in the superficial capillary plexus (SCP) and deep capillary plexus (DCP): the area of foveal avascular zone, number of microaneurysms (MA), area of cysts, and presence of capillary network alterations. Microaneurysm change was also evaluated in 15 fellow eyes, not needing treatment over 6 months. Vessel and perfusion densities were evaluated in the SCP, DCP, and choriocapillaris, with image J. Retina thickness, number of hyperreflective retinal spots, and external limiting membrane integrity were evaluated on OCT. All measurements were performed by two masked graders, independently.
RESULTS: All patients had diabetes mellitus Type 2 (mean age, 69.4 ± 10.9 years; duration of diabetes mellitus, 15.7 ± 8.7 years; and HbA1c 7.7 ± 1.2%). Mean best-corrected visual acuity at baseline was 69.7 ± 12.0 letters ETDRS, 72.7 ± 10.7 at 3 months (gain 3.1 ± 4.3, P = 0.0049) and 74.3 ± 9.5 at 6 months (gain 4.6 ± 7.2, P < 0.0001). Foveal avascular zone area decreased in the DCP at 6 months (P = 0.01). Area of cysts decreased in the SCP at 3 months and 6 months (P = 0.038; P = 0.049), and in the DCP at 6 months (P = 0.0071). Number of MA decreased at 6 months in the SCP (P = 0.0007) and at 3 months and 6 months in the DCP (P = 0.048; P < 0.0001) in treated eyes. No significant change in number of MA was found in nontreated eyes. There was no statistically significant change in any other OCT angiography/OCT parameter.
CONCLUSION: Subthreshold micropulse yellow laser induces more pronounced changes in the DCP than in the SCP in DME. These changes occurred as early as 3 months after treatment. The evaluation of specific parameters in the DCP may help in determining treatment response.

Entities:  

Mesh:

Year:  2020        PMID: 31972802     DOI: 10.1097/IAE.0000000000002383

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  11 in total

1.  Investigation of the therapeutic mechanism of subthreshold micropulse laser irradiation in retina.

Authors:  Kazutaka Hirabayashi; Shinji Kakihara; Masaaki Tanaka; Takayuki Shindo; Toshinori Murata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-03-05       Impact factor: 3.117

2.  Optical coherence tomography angiography assessment of 577 nm laser effect on severe non-proliferative diabetic retinopathy with diabetic macular edema.

Authors:  Zi-Jing Li; Jian-Hui Xiao; Peng Zeng; Rui Zeng; Xiang Gao; Yi-Chi Zhang; Yu-Qing Lan
Journal:  Int J Ophthalmol       Date:  2020-08-18       Impact factor: 1.779

3.  Sub-threshold nanosecond laser (SNL) treatment in intermediate AMD (IAMD).

Authors:  R Theodore Smith
Journal:  Ann Eye Sci       Date:  2019-01-10

4.  Comparison of two-year treatment outcomes between subthreshold micropulse (577 nm) laser and aflibercept for diabetic macular edema.

Authors:  Frank Hiu Ping Lai; Rose P S Chan; Anthony C H Lai; Susanna Tsang; Tiffany T Y Woo; Robert F Lam; Can Y F Yuen
Journal:  Jpn J Ophthalmol       Date:  2021-06-14       Impact factor: 2.447

Review 5.  Micropulse Laser Treatment of Retinal Diseases.

Authors:  Maciej Gawęcki
Journal:  J Clin Med       Date:  2019-02-13       Impact factor: 4.241

6.  Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers.

Authors:  Stela Vujosevic; Caterina Toma; Edoardo Villani; Marco Brambilla; Emanuele Torti; Francesco Leporati; Andrea Muraca; Paolo Nucci; Stefano De Cilla
Journal:  Transl Vis Sci Technol       Date:  2020-09-30       Impact factor: 3.283

7.  Subthreshold micropulse laser adjuvant to bevacizumab versus bevacizumab monotherapy in treating diabetic macular edema: one- year- follow-up.

Authors:  Leila El Matri; Ahmed Chebil; Khaled El Matri; Yousra Falfoul; Zouheir Chebbi
Journal:  Ther Adv Ophthalmol       Date:  2021-09-02

8.  Differentiating features of OCT angiography in diabetic macular edema.

Authors:  Reza Mirshahi; Hamid Riazi-Esfahani; Elias Khalili Pour; Kaveh Fadakar; Parsa Yarmohamadi; Sayyed Amirpooya Alemzadeh; Samira Chaibakhsh; Khalil Ghasemi Falavarjani
Journal:  Sci Rep       Date:  2021-12-03       Impact factor: 4.379

9.  Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study.

Authors:  Vincenza Bonfiglio; Robert Rejdak; Katarzyna Nowomiejska; Sandrine Anne Zweifel; Maximilian Robert Justus Wiest; Giovanni Luca Romano; Claudio Bucolo; Lucia Gozzo; Niccolò Castellino; Clara Patane; Corrado Pizzo; Michele Reibaldi; Andrea Russo; Antonio Longo; Matteo Fallico; Iacopo Macchi; Maria Vadalà; Teresio Avitabile; Ciro Costagliola; Kamil Jonak; Mario Damiano Toro
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

Review 10.  Review of clinical studies and recommendation for a therapeutic flow chart for diabetic macular edema.

Authors:  Shigeo Yoshida; Tomoaki Murakami; Miho Nozaki; Kiyoshi Suzuma; Takayuki Baba; Takao Hirano; Osamu Sawada; Masahiko Sugimoto; Yoshihiro Takamura; Eiko Tsuiki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-09-30       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.